Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 259 KB, PDF document
Aims Outcomes after myocardial infarction (MI) improved during recent decades alongside better risk factor management and implementation of guideline-recommended treatments. However, it is unknown whether this applies to stable patients who are event-free 1 year after MI. Methods and results Using nationwide Danish registries, we included all patients with first-time MI during 2000-17 who survived 1 year free from bleeding and cardiovascular events (n = 82 108, median age 64 years, 68.2% male). Follow-up started 1 year after MI and continued through January 2022. Crude risks of mortality, cardiovascular events, and bleeding were estimated in consecutive 3-year periods. Standardized risks were calculated with respect to the distribution of age, sex, comorbidities, and treatments in the latter period. Guideline-recommended treatment use increased during the study period: e.g. statins (68.6-92.5%) and percutaneous coronary intervention (23.9-68.2%). The crude 5-year risks of outcomes decreased (all P-trend
Original language | English |
---|---|
Journal | European Heart Journal |
Volume | 44 |
Issue number | 6 |
Pages (from-to) | 488–498 |
Number of pages | 11 |
ISSN | 0195-668X |
DOIs | |
Publication status | Published - 2023 |
- myocardial infarction stable, Guidelines, long-term risk, Registry, outcomes, DUAL ANTIPLATELET THERAPY, FIBRINOLYTIC THERAPY, FOCUSED UPDATE, TASK-FORCE, 2017 ESC, ELEVATION, ASSOCIATION, MANAGEMENT, DISEASE, RISK
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 328728887